|
| Michael
Macken
C.E.O. of Pharmaplaz, LTD
Director
of Samaritan Pharmaceuticals, Ireland
Sorrento, Creah
Baile na Mulla, Athlone
IRELAND (REPUBLIC)
e-mail
Michael
|
|
 SAMARITAN
IRELAND
Manufacturing
Samaritan
Pharmaceuticals Inc., and Pharmaplaz LTD, a fully integrated
healthcare company operating under cGMP with a manufacturing
licence under EMEA, have entered into a broad strategic collaboration
agreement for the production and supply of Samaritan's lead
compound SP-01A.
The European
Agency for the Evaluation of Medicinal Products (EMEA) is
the European counterpart to the US Food and Drug Administration
(FDA).
Under
the terms of the alliance, Pharmaplaz will collaborate with
Samaritan's SP-01A development, scale up, and manufacturing
requirements, while working on drug formulation and testing,
production of pilot batches, development of analytical methods,
drug specifications, process validations and drug optimization.
The companies will also work together to secure regulatory
approval by the FDA for selected products in the U.S. markets.
Samaritan
Pharmaceuticals, Ireland creates a virtual in-house facility;
eliminating the hiring of contract manufacturers, savings
could amount to as much as $500,000 per drug. Attractive tax
breaks have turned Ireland into a major drug manufacturing
center, with 13 of the top 15 drug makers now in Ireland.
|
